Human natural killer cells in asymptomatic human immunodeficiency virus-1 Infection

被引:0
|
作者
Hulström, AL
Hejdeman, B
Leandersson, AC
Bratt, G
Carbone, E
Wahren, B [1 ]
机构
[1] Swedish Inst Infect Dis Control, Dept Virol, Microbiol & Tumorbiol Ctr, SE-17182 Solna, Sweden
[2] Karolinska Inst, South Hosp, Dept Venereol, Stockholm, Sweden
[3] Swedish Inst Infect Dis Control, Microbiol & Tumorbiol Ctr, Stockholm, Sweden
关键词
NK cells; HIV-1; DNA vaccine;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Objectives: We evaluated whether DNA immunization with HIV-1 regulatory genes change natural killer (NK) effector cell activity. NK cells are the most important cells for the immediate host defense against virus-infected and tumor cells. We analyzed the NK activities of HIV-1-infected individuals against K562 cells (the classical assay) as well as against a CD4+ cell line with and without HIV-7 infection. CD4+ T lymphocytes are the main target cells for HIV-7 infection in vivo. Various proportions of the CD4+ T lymphocyte population carry the HIV-1 genome, produce virus and contribute to the systemic spread of HIV-1. Methods: CD4+ cell lines were established through HTLV-1 transformation which made the cells susceptible to NK lysis, NK activity was then tested in a Cr-51 release assay. Results: NK cells of asymptomatic HIV-infected individuals mediated considerable lytic activity against K562 cells as well as against the uninfected and HIV-1-infected CD4+ cell line, and so did the NK cells of HIV-1-infected patients on highly active antiretroviral treatment. Conclusion: DNA immunization with HIV-7-regulatory genes did not significantly change the NK effector cell activity. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:294 / 301
页数:8
相关论文
共 50 条
  • [1] Human Uterine Natural Killer Cells but Not Blood Natural Killer Cells Inhibit Human Immunodeficiency Virus Type 1 Infection by Secretion of CXCL12
    Mselle, Teddy F.
    Howell, Alexandra L.
    Ghosh, Mimi
    Wira, Charles R.
    Sentman, Charles L.
    JOURNAL OF VIROLOGY, 2009, 83 (21) : 11188 - 11195
  • [2] IMMUNOHISTOCHEMICAL EVIDENCE FOR HUMAN IMMUNODEFICIENCY VIRUS-1 INFECTION OF LIVER KUPFFER CELLS
    HOUSSET, C
    BOUCHER, O
    GIRARD, PM
    LEIBOWITCH, J
    SAIMOT, AG
    BRECHOT, C
    MARCHE, C
    HUMAN PATHOLOGY, 1990, 21 (04) : 404 - 408
  • [3] Putative roles of purinergic signaling in human immunodeficiency virus-1 infection
    Pacheco, Paulo A. F.
    Faria, Robson X.
    Ferreira, Leonardo G. B.
    Paixao, Izabel C. N. P.
    BIOLOGY DIRECT, 2014, 9 : 21
  • [4] Natural Killer Cell Receptors in Human Immunodeficiency Virus Infection: Pathways to Protection or Doors to Disappointment?
    Parsons, Matthew S.
    Grant, Michael
    CURRENT HIV RESEARCH, 2009, 7 (05) : 487 - 496
  • [5] INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS-1 PROTEASE
    TYAGI, SC
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1992, 70 (05): : 309 - 315
  • [6] Dynamics of Human Immunodeficiency Virus-1 Genetic Diversification During Acute Infection
    Song, Hongshuo
    Bose, Meera
    Pinyakorn, Suteeraporn
    Sanders-Buell, Eric
    O'Sullivan, Anne Marie
    Silas, Daniel
    Trichavaroj, Rapee
    Nuntapinit, Bessara
    Pham, Phuc T.
    Akapirat, Siriwat
    Kroon, Eugene
    de Souza, Mark
    Gramzinski, Robert
    Michael, Nelson L.
    Robb, Merlin L.
    Vasan, Sandhya
    Tovanabutra, Sodsai
    Ananworanich, Jintanat
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (10): : 1 - 4
  • [7] Tracking Human Immunodeficiency Virus-1 Infection in the Humanized DRAG Mouse Model
    Kim, Jiae
    Peachman, Kristina K.
    Jobe, Ousman
    Morrison, Elaine B.
    Allam, Atef
    Jagodzinski, Linda
    Casares, Sofia A.
    Rao, Mangala
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [8] Functional Invariant Natural Killer T Cells Secreting Cytokines Are Associated With Non-Progressive Human Immunodeficiency Virus-1 Infection but Not With Suppressive Anti-Retroviral Treatment
    Singh, Dharmendra
    Ghate, Manisha
    Godbole, Sheela
    Kulkarni, Smita
    Thakar, Madhuri
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Cabotegravir in the treatment and prevention of Human Immunodeficiency Virus-1
    McPherson, Tristan D.
    Sobieszczyk, Magdalena E.
    Markowitz, Martin
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (04) : 413 - 420
  • [10] Analysis of the human immunodeficiency virus-1 RNA packageome
    Eckwahl, Matthew J.
    Arnion, Helene
    Kharytonchyk, Siarhei
    Zang, Trinity
    Bieniasz, Paul D.
    Telesnitsky, Alice
    Wolin, Sandra L.
    RNA, 2016, 22 (08) : 1228 - 1238